| Trial ID: | L3438 |
| Source ID: | NCT00696163
|
| Associated Drug: |
Biphasic Insulin Aspart 30
|
| Title: |
Observational Study to Assess the Quality of Life and Clinical Outcomes in Subjects Using NovoMix® 30 for the Treatment of Diabetes
|
| Acronym: |
IMPROVE Life
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: biphasic insulin aspart 30
|
| Outcome Measures: |
Primary: Change in Quality of Life from baseline (using QoLD questionnaire), From baseline to 26 weeks of treatment | Secondary: Safety, After 26 weeks|Efficacy, After 26 weeks
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
24975
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2008-04
|
| Completion Date: |
2009-03
|
| Results First Posted: |
|
| Last Update Posted: |
2016-10-31
|
| Locations: |
Novo Nordisk Investigational Site, Bangalore, 560001, India
|
| URL: |
https://clinicaltrials.gov/show/NCT00696163
|
